지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.3
- 수록면
- 71 - 78 (8page)
- DOI
- 10.24304/kjcp.2024.34.1.71
이용수
초록· 키워드
오류제보하기
Background: Oral cancer drugs, particularly tyrosine kinase inhibitors (TKIs), are increasingly popular due to their convenience.
However, they pose challenges like drug interactions, especially with medications like azole antifungals. While the FDA provides some guidance, more detailed information is needed to manage these interactions effectively. A meta-analysis was conducted to understand the impact of interactions between TKIs and azole antifungals on adverse events during clinical studies. Methods: A meta-analysis followed PRISMA guidelines. Data from PubMed, EMBASE, and references were searched until November 30, 2021. Inclusion criteria encompassed studies on TKI-antifungal interactions in English. Study selection and quality assessment were conducted by two independent investigators. Results: Out of 158 articles, 11 were selected for analysis. Combination ther apy showed a slight increase in adverse events but was not statistically significant (OR 1.02, 95% CI 0.49-2.13, p=0.95). AUC and Cmax fold changes did not significantly impact adverse event development. Both itraconazole and ketoconazole showed no significant difference in adverse event development compared to TKI alone. Conclusions: Study finds TKI-DDI not significantly linked to AE increase; azole antifungal types not related to AE. Future DDI research crucial for drug development
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
진행성 갑상선암 환자에서 발생하는 Tyrosine Kinase Inhibitor의 이상반응
International Journal of Thyroidology
2018 .01
-
방사성요오드 불응성 갑상선암에서 티로신키나아제억제제 투여로 유발된 중증 피로감의 관리
International Journal of Thyroidology
2018 .01
-
티로신 키나아제 저해제의 간독성에 대한 고찰
한국임상약학회지
2019 .01
-
티로신키나아제 억제제 치료 후 발생한 중증 저칼슘혈증및 갑상선기능저하증 1례
International Journal of Thyroidology
2018 .01
-
만성골수성백혈병의 타이로신인산화효소 억제제 치료 중 발생하는 혈관합병증
대한의사협회지
2023 .04
-
Prediction of Drug–Drug Interactions by Using Profile Fingerprint Vectors and Protein Similarities
Healthcare Informatics Research
2020 .01
-
Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation
Blood Research
2023 .04
-
Adverse Drug Reaction in the Neonatal Intensive Care Unit: A Single Center Study
Neonatal medicine
2015 .01
-
의약품 부작용 피해구제 제도
대한내과학회지
2018 .01
-
CORRIGENDUM: CORRECTION OF TEXT. 진행성 갑상선암 환자에서 발생하는 Tyrosine Kinase Inhibitor의 이상반응
International Journal of Thyroidology
2019 .01
-
Drug-drug interactions with direct-acting antivirals ? less is more
Clinical and Molecular Hepatology
2021 .01
-
약물군-약물군 조합으로 도출한 약력학적 기전의 추가 병용금기성분
한국임상약학회지
2015 .01
-
정신약물에 의한 피부 부작용
생물치료정신의학
2017 .10
-
노인 심혈관질환의 다약제 포괄관리
대한의사협회지
2024 .07
-
면역관문억제제 투여 환자의 간기능 이상반응 분석
병원약사회지
2022 .11
-
Effects of an Epithelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Add-on in Stereotactic Radiosurgery for Brain Metastases Originating from Non-Small-Cell Lung Cancer
대한신경외과학회지
2015 .01
-
약물이상반응에 대한 응급구조학과 학생의 지식과 태도 조사
한국응급구조학회지
2021 .12
-
중환자의 카바페넴 내성 Acinetobacter baumannii 폐렴 치료 시 발생한 이상사례와 위험 인자
병원약사회지
2019 .01
-
Severe Adverse Drug Reactions in Korean Elderly Patients
Korean Journal of Family Medicine
2022 .03
최근 본 자료
댓글(0)
0